Clinical trial
Conversion to Monotherapy Study With Keppra XR for Partial Seizures
NCT00419094 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00419094 |
|---|---|
| Title | Conversion to Monotherapy Study With Keppra XR for Partial Seizures |
| Official title | A Multi-center, Double-blind, Historical Control, Randomized Conversion to Monotherapy Study With Keppra XR for Treatment of Partial Onset Seizures |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Keppra XR |
| Enrollment | 228 |
| Start date | Aug 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jan 8, 2007 |
| Last update posted | Sep 5, 2014 |
| Countries | Mexico, Poland, Russia, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: